Cargando…

Screening and clinical significance of lymph node metastasis‐related genes within esophagogastric junction adenocarcinoma

BACKGROUND: Despite recent improvements in treatment technologies, such as surgical resection and chemoradiotherapy, the prognosis of patients with esophagogastric junction adenocarcinoma (EJA) remains poor due to early lymph node metastasis. Since few studies have investigated genes associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Rui, Chen, Gang, Li, Meng, Peng, Zhong‐Min, Xu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335809/ https://www.ncbi.nlm.nih.gov/pubmed/34152098 http://dx.doi.org/10.1002/cam4.4065

Ejemplares similares

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017)

Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance
por: Zhang, Xu, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma
por: Lee, In-Seob, et al.
Publicado: (2017)

Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study
por: Chen, Liubo, et al.
Publicado: (2021)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Organotypic slice cultures of human gastric and esophagogastric junction cancer
por: Koerfer, Justus, et al.
Publicado: (2016)

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures
por: Duan, Xiao-Feng, et al.
Publicado: (2017)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

Endoscopic Versus Surgical Therapy for Early Esophagogastric Junction Adenocarcinoma Based on Lymph Node Metastasis Risk: A Population-Based Analysis
por: Ye, Hua, et al.
Publicado: (2021)

Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection
por: Zhang, Hongdian, et al.
Publicado: (2016)

High‐risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma
por: Yura, Masahiro, et al.
Publicado: (2018)

Impacts of neoadjuvant therapy on the number of dissected lymph nodes in esophagogastric junction cancer patients
por: Wang, Qi, et al.
Publicado: (2023)

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction
por: Xu, Jinming, et al.
Publicado: (2017)

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
por: Kamiya, Hajime, et al.
Publicado: (2023)

Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia
por: Oh, Sung Eun, et al.
Publicado: (2023)

HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma
por: Wang, Zhao Yang, et al.
Publicado: (2021)

Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction
por: Ma, Rui-Jie, et al.
Publicado: (2022)

Feasibility of using negative ultrasonography results of axillary lymph nodes to predict sentinel lymph node metastasis in breast cancer patients
por: Chen, Xue, et al.
Publicado: (2018)

Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction
por: O’Riordan, James M., et al.
Publicado: (2007)

LINC00636 promotes lymph node metastasis and cervical cancer through targeting NM23
por: Zhong, Yue, et al.
Publicado: (2020)

Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma
por: Zhu, Xiaoke, et al.
Publicado: (2020)

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma
por: Werner, Dominique, et al.
Publicado: (2013)

Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis‐related genes based on the Cancer Genome Atlas
por: Dong, Ming, et al.
Publicado: (2019)

Comparison of lymph node metastasis pattern from esophagogastric junction adenocarcinoma versus very low thoracic esophageal squamous cancer: a propensity-matched analysis
por: Ma, Zhao, et al.
Publicado: (2023)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
por: Urabe, Masayuki, et al.
Publicado: (2018)

Mapping of lymph node dissection determined by the epicenter location and tumor extension for esophagogastric junction carcinoma
por: Liang, Rong, et al.
Publicado: (2022)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis
por: Chen, Jingyu, et al.
Publicado: (2020)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014)

Association of miRNA-499 rs3746444 A>G variants with adenocarcinoma of esophagogastric junction (AEG) risk and lymph node status
por: Tang, Weifeng, et al.
Publicado: (2019)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)

Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis
por: Duraker, Nüvit, et al.
Publicado: (2011)

Risk Factors and Prognostic Significance of Retropancreatic Lymph Nodes in Gastric Adenocarcinoma
por: Xue, Lian, et al.
Publicado: (2015)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9oce3qmfjau8ktpop28gfeu1kl